PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Behavioral therapy provided during dialysis sessions may combat depression among kidney failure patients

Treatments may help the 20 to 44 percent of patients with kidney failure who struggle with depression

2013-10-12
(Press-News.org) Washington, DC (October 10, 2013) — Behavioral therapy provided chair-side to kidney failure patients while they're undergoing dialysis may help fight depression and improve patients' quality of life, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

Thanks to advances in medical technology, dialysis patients have the potential to live longer and healthier lives than ever before, but depression is a serious and prevalent problem among them. In addition to taking a toll on individuals' emotional health, depression has also been linked with shortened life spans in dialysis patients. Traditional treatments include either medication or psychotherapy, but dialysis patients are usually on many medications and seldom have the time or energy for additional outpatient appointments.

Daniel Cukor, PhD (SUNY Downstate Medical Center) and his colleagues addressed this hurdle by providing a specially adapted cognitive behavioral therapy for depression that is provided chair-side, while patients are undergoing dialysis. Cognitive behavioral therapy teaches a patient to learn effective self-help skills that help change the way the person currently thinks, feels and behaves. It is action-oriented and helps the patient gain independence and mastery in dealing with issues. "We believe such an intervention is eminently practical and feasible for implementation in dialysis units," explained Dr. Cukor.

The research team tested their strategy in 59 patients undergoing treatment at dialysis centers in New York. In 33 patients, cognitive behavioral therapy was administered chair-side during dialysis treatments for three months. Another 26 patients did not receive behavioral therapy during dialysis. Patients were assessed three and six months later.

Among the major findings: The treatment group achieved significantly larger reductions in depression scores compared with the control group. Among participants with depression diagnosed at the start of the study, 89% in the treatment group were not depressed at the end of treatment, compared with 38% in the control group. Patients in the treatment group experienced greater improvements in quality of life and were better able to control fluid intake between dialysis sessions (which makes the next dialysis session more efficient).

"We were able to have a substantial and positive impact on the level of depression, quality of life, and fluid adherence of dialysis patients, without using any medication and only minimal additional treatment burden on the patient," said Dr. Cukor. "These results are novel and encouraging, as they indicate that despite the complex challenges of life on dialysis, there are now tools that are available to the clinician to address depression in patients."

###

Study co-authors include Nisha Ver Halen, PhD, Deborah Rosenthal Asher, PhD, Jeremy Coplan, MD, Jeremy Weedon, PhD, Katarzyna Wyka, PhD, Subodh Saggi, MD, Paul Kimmel, MD.

Disclosures: The authors reported no financial disclosures.

The article, entitled "Psychosocial Intervention Improves Depression, Quality of Life, and Fluid Adherence in Hemodialysis," is now online at http://jasn.asnjournals.org/, doi: 10.1681/ASN2012111134.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 14,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

END



ELSE PRESS RELEASES FROM THIS DATE:

Cartilage damage could be repaired

2013-10-11
Unlike our bones, the cartilage inside our joints is not vascularized (i.e., it has no blood vessels). This is one reason why cartilage does not heal well after an injury. In athletes in particular, joint injuries often result in cartilage degeneration and arthritis. The process is chronic and irreversible, and to this day, no effective treatment exists. EPFL scientists Dominique Pioletti and Harm-Anton Klok have developed a hydrogel that promotes cartilage regeneration. In a joint, cartilage-producing cells only respond to treatment if they are mechanically stimulated ...

Crystals in Picabo's rocks point to 'recycled' super-volcanic magma chambers

2013-10-11
EUGENE, Ore. -- (Oct. 11, 2013) -- A thorough examination of tiny crystals of zircon, a mineral found in rhyolites, an igneous rock, from the Snake River Plain has solidified evidence for a new way of looking at the life cycle of super-volcanic eruptions in the long track of the Yellowstone hotspot, say University of Oregon scientists. The pattern emerging from new and previous research completed in the last five years under a National Science Foundation career award, said UO geologist Ilya N. Bindeman, is that another super-eruption from the still-alive Yellowstone volcanic ...

Cell growth discovery by UCSF team has implications for targeting cancer

2013-10-11
The way cells divide to form new cells — to support growth, to repair damaged tissues, or simply to maintain our healthy adult functioning — is controlled in previously unsuspected ways UC San Francisco researchers have discovered. The findings, they said, may lead to new ways to fight cancer. The steps leading a quiet cell to make and divvy up new parts to form daughter cells rely on some of the cell’s most complex molecular machines. Different machines play key roles at different stages of this cell cycle. Each of these cellular machines consists of many proteins ...

Researchers find rust can power up artificial photosynthesis

2013-10-11
CHESTNUT HILL, MA (Oct. 11, 2013) – Chemists at Boston College have achieved a series of breakthroughs in their efforts to develop an economical means of harnessing artificial photosynthesis by narrowing the voltage gap between the two crucial processes of oxidation and reduction, according to their latest research, published this week in the journal Angewandte Chemie. The team reports it has come within two-tenths of the photovoltage required to mimic oxidation and reduction respectively using unique photoanodes and photocathodes the team developed using novel nanowire ...

Uniformity: The secret of better fusion ignition

2013-10-11
One of the ways to achieve thermonuclear fusion is through a controlled reaction between two light variants of hydrogen, called deuterium and tritium. Mauro Temporal, from the École Normale Supérieure Cachan, in France, and colleagues have made theoretical calculations indicating how best to improve the ignition stage of fusion reaction. Their approach, described in a paper published in EPJ D, involves increasing the uniformity of irradiation using high-power laser beams on the external shell of a spherical capsule containing a mix of deuterium and tritium. Reaching ...

Turning vapors into foam-like polymer coatings

2013-10-11
Polymers -- the essential component of plastics -- are found in countless commercial, medical, and industrial products. Polymers that are porous are called foam polymers and are especially useful because they combine light weight with rigid mechanical properties. Now a researcher at the University of Rochester has developed a process to grow highly customizable coatings of foam-like polymers. The process, developed by Mitchell Anthamatten, a chemical engineer at the University's Hajim School of Engineering and Applied Science, involves growing foam polymers directly from ...

CNIO researchers discover a new regulator of drug detoxication

2013-10-11
Drug abuse and alcohol are some of the most frequent causes of liver damage, particularly in developed countries. Such kind of liver damage can cause irreversible liver failure and even cancer. Researchers from the Spanish National Cancer Research Centre (CNIO) have discovered an important new protective role of the Fra-1 protein, which neutralizes the damage caused by agents, such as the analgesic drug acetaminophen (Paracetamol). This is the first study to reveal a function of Fra-1 in protecting this important organ. The study is published today in the journal Hepatology. The ...

Badgers ultimately responsible for around half of TB in cattle, study estimates

2013-10-11
Badgers are ultimately responsible for roughly half of tuberculosis (TB) in cattle in areas with high TB prevalence, according to new estimates based on data from a previous badger culling trial. However, only around six per cent of infected cattle catch TB from badgers, with onward transmission between cattle herds accounting for the remainder, the study suggests. The findings are published in the journal PLOS Currents: Outbreaks. The role of badgers in spreading bovine TB has been debated intensely as part of discussions about whether badgers should be culled to control ...

Targeted treatment plus chemotherapy could benefit women with ovarian cancer

2013-10-11
Conventional chemotherapy could further extend life in some women with ovarian cancer when used in tandem with a new type of targeted treatment, a new international study shows. The research, published in the October issue of the journal Clinical Cancer Research, provides important evidence that PARP inhibitor drugs and chemotherapy can both be effective in the same patients, helping women live longer than they would if treated with chemotherapy alone. The study, in women with mutations to BRCA genes – which increase the risk that ovarian cancer will relapse after treatment, ...

Packaging stem cells in capsules for heart therapy

2013-10-11
Stem cell therapy for heart disease is happening. Around the world, thousands of heart disease patients have been treated in clinical studies with some form of bone marrow cells or stem cells. But in many of those studies, the actual impact on heart function was modest or inconsistent. One reason is that most of the cells either don't stay in the heart or die soon after being introduced into the body. Cardiology researchers at Emory have a solution for this problem. The researchers package stem cells in a capsule made of alginate, a gel-like substance. Once packaged, ...

LAST 30 PRESS RELEASES:

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

AERA announces winners of the 2025 Palmer O. Johnson Memorial Award

Mapping minds: The neural fingerprint of team flow dynamics

Patients support AI as radiologist backup in screening mammography

AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy

Existing drug has potential for immune paralysis

[Press-News.org] Behavioral therapy provided during dialysis sessions may combat depression among kidney failure patients
Treatments may help the 20 to 44 percent of patients with kidney failure who struggle with depression